HomeCompareYDRMF vs JNJ

YDRMF vs JNJ: Dividend Comparison 2026

YDRMF yields 1784.12% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YDRMF wins by $3445322477.78M in total portfolio value
10 years
YDRMF
YDRMF
● Live price
1784.12%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3445322477.81M
Annual income
$3,103,170,516,291,968.50
Full YDRMF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — YDRMF vs JNJ

📍 YDRMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodYDRMFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, YDRMF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
YDRMF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

YDRMF
Annual income on $10K today (after 15% tax)
$151,650.31/yr
After 10yr DRIP, annual income (after tax)
$2,637,694,938,848,173.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, YDRMF beats the other by $2,637,694,938,844,187.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of YDRMF + JNJ for your $10,000?

YDRMF: 50%JNJ: 50%
100% JNJ50/50100% YDRMF
Portfolio after 10yr
$1722661238.92M
Annual income
$1,551,585,258,148,329.00/yr
Blended yield
90.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

YDRMF
No analyst data
Altman Z
-52.1
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

YDRMF buys
0
JNJ buys
0
No recent congressional trades found for YDRMF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricYDRMFJNJ
Forward yield1784.12%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$3445322477.81M$30.3K
Annual income after 10y$3,103,170,516,291,968.50$4,689.40
Total dividends collected$3420810643.82M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: YDRMF vs JNJ ($10,000, DRIP)

YearYDRMF PortfolioYDRMF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$189,112$178,412.13$10,592$272.30+$178.5KYDRMF
2$3,355,612$3,153,261.56$11,289$357.73+$3.34MYDRMF
3$55,881,692$52,291,187.78$12,123$472.89+$55.87MYDRMF
4$873,640,095$813,846,684.04$13,141$629.86+$873.63MYDRMF
5$12,825,889,375$11,891,094,473.39$14,408$846.81+$12825.87MYDRMF
6$176,875,920,430$163,152,218,799.19$16,021$1,151.60+$176875.90MYDRMF
7$2,292,020,734,574$2,102,763,499,713.60$18,122$1,588.22+$2292020.72MYDRMF
8$27,918,212,780,997$25,465,750,595,003.23$20,930$2,228.20+$27918212.76MYDRMF
9$319,768,188,330,874$289,895,700,655,206.94$24,792$3,191.91+$319768188.31MYDRMF
10$3,445,322,477,806,004$3,103,170,516,291,968.50$30,274$4,689.40+$3445322477.78MYDRMF

YDRMF vs JNJ: Complete Analysis 2026

YDRMFStock

YDx Innovation Corp., a technology company that develops augmented and virtual reality, esports events, and interactive exhibitions technologies in Canada and Brazil. Its Arkave VR Arena division operates a gaming platform for virtual reality experience to location based venues. The company's YDreams Global division develops interactive experiences for conceptual spaces and exhibitions. Its offers Game On Festival, a format of esports events that combines digital storytelling and competitive gaming. The company was formerly known as YDreams Global Interactive Technologies Inc. and changed its name to YDx Innovation Corp. in January 2019. YDx Innovation Corp. was founded in 2007 and is headquartered in Vancouver, Canada.

Full YDRMF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this YDRMF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

YDRMF vs SCHDYDRMF vs JEPIYDRMF vs OYDRMF vs KOYDRMF vs MAINYDRMF vs ABBVYDRMF vs MRKYDRMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.